|
Mar 4
|
Stereotaxis Inc (STXS) Faces Revenue Pressure Amid Strategic Transformation
|
|
Mar 4
|
Stereotaxis Announces Regulatory Submissions of the MAGiC Ablation Catheter in Europe and the United States
|
|
Mar 4
|
Stereotaxis Reports 2023 Full Year Financial Results
|
|
Nov 28
|
Baptist Health Lexington Enhances 20-Year Leadership in Pioneering Advanced Robotic Technology for Heart Disease Patients
|
|
Sep 28
|
AxoGen (AXGN) Moves 6.8% Higher: Will This Strength Last?
|
|
Aug 16
|
Live Long-Distance TeleRobotic Procedures to Highlight Stereotaxis Technology at Asia Pacific Heart Rhythm Symposium
|
|
Jul 20
|
Stereotaxis to Report Second Quarter 2023 Financial Results on August 10, 2023
|
|
Jul 18
|
Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients
|